Strous RD - Search Results

1

The relevance of neurosteroids to clinical psychiatry: from the laboratory to the bedside.

Strous RD, Maayan R, Weizman A. Strous RD, et al. Eur Neuropsychopharmacol. 2006 Apr;16(3):155-69. doi: 10.1016/j.euroneuro.2005.09.005. Epub 2005 Oct 27. Eur Neuropsychopharmacol. 2006. PMID: 16257183 Review.

2

Neurosteroids in child and adolescent psychopathology.

Golubchik P, Lewis M, Maayan R, Sever J, Strous R, Weizman A. Golubchik P, et al. Eur Neuropsychopharmacol. 2007 Feb;17(3):157-64. doi: 10.1016/j.euroneuro.2006.08.003. Epub 2006 Oct 31. Eur Neuropsychopharmacol. 2007. PMID: 17079119 Review.

3

Lowered DHEA-S plasma levels in adult individuals with autistic disorder.

Strous RD, Golubchik P, Maayan R, Mozes T, Tuati-Werner D, Weizman A, Spivak B. Strous RD, et al. Eur Neuropsychopharmacol. 2005 May;15(3):305-9. doi: 10.1016/j.euroneuro.2004.12.004. Eur Neuropsychopharmacol. 2005. PMID: 15820420

4

Circulatory neurosteroid levels in smoking and non-smoking chronic schizophrenia patients.

Iancu I, Tchernihovsky E, Maayan R, Poreh A, Dannon P, Kotler M, Weizman A, Strous RD. Iancu I, et al. Among authors: strous rd. Eur Neuropsychopharmacol. 2007 Jul;17(8):541-5. doi: 10.1016/j.euroneuro.2007.02.001. Epub 2007 Mar 8. Eur Neuropsychopharmacol. 2007. PMID: 17346944

5

Improvement of aggressive behavior and quality of life impairment following S-adenosyl-methionine (SAM-e) augmentation in schizophrenia.

Strous RD, Ritsner MS, Adler S, Ratner Y, Maayan R, Kotler M, Lachman H, Weizman A. Strous RD, et al. Eur Neuropsychopharmacol. 2009 Jan;19(1):14-22. doi: 10.1016/j.euroneuro.2008.08.004. Epub 2008 Sep 27. Eur Neuropsychopharmacol. 2009. PMID: 18824331 Clinical Trial.

6

DHEA and DHEA-S levels in hospitalized adolescents with first-episode schizophrenia and conduct disorder: a comparison study.

Strous RD, Maayan R, Kaminsky M, Blumensohn R, Weizman A, Spivak B. Strous RD, et al. Eur Neuropsychopharmacol. 2009 Jul;19(7):499-503. doi: 10.1016/j.euroneuro.2009.03.001. Epub 2009 Apr 5. Eur Neuropsychopharmacol. 2009. PMID: 19351578 No abstract available.

7

Elevation of the cortisol/dehydroepiandrosterone ratio in schizophrenia patients.

Ritsner M, Maayan R, Gibel A, Strous RD, Modai I, Weizman A. Ritsner M, et al. Among authors: strous rd. Eur Neuropsychopharmacol. 2004 Aug;14(4):267-73. doi: 10.1016/j.euroneuro.2003.09.003. Eur Neuropsychopharmacol. 2004. PMID: 15163435

8

Analysis of neurosteroid levels in attention deficit hyperactivity disorder.

Strous RD, Spivak B, Yoran-Hegesh R, Maayan R, Averbuch E, Kotler M, Mester R, Weizman A. Strous RD, et al. Int J Neuropsychopharmacol. 2001 Sep;4(3):259-64. doi: 10.1017/S1461145701002462. Int J Neuropsychopharmacol. 2001. PMID: 11602031 Free article. Clinical Trial.

9

Involvement of GABAA receptor modulating neuroactive steroids in patients with social phobia.

Laufer N, Maayan R, Hermesh H, Marom S, Gilad R, Strous R, Weizman A. Laufer N, et al. Psychiatry Res. 2005 Nov 15;137(1-2):131-6. doi: 10.1016/j.psychres.2005.07.003. Epub 2005 Oct 13. Psychiatry Res. 2005. PMID: 16226317

10

Increased circulatory dehydroepiandrosterone and dehydroepiandrosterone-sulphate in first-episode schizophrenia: relationship to gender, aggression and symptomatology.

Strous RD, Maayan R, Lapidus R, Goredetsky L, Zeldich E, Kotler M, Weizman A. Strous RD, et al. Schizophr Res. 2004 Dec 1;71(2-3):427-34. doi: 10.1016/j.schres.2004.03.005. Schizophr Res. 2004. PMID: 15474914

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

168 results

Search Page

Filters